Co-Diagnostics, Inc. (Nasdaq: CODX) ("Co-Dx" or "the Company"), a molecular diagnostics company with a unique, patented ...

The new HER2DX central nervous system (CNS) progression score predicts risk of brain progression in advanced HER2+ breast cancer, addressing a major unmet need in identifying patients at the highest ...

For many students and young adults, hearing about the Rice Purity Test can be a bit confusing. You might have seen friends ...

The American Cancer Society has recently updated cervical screening guidelines for HPV and cervical cancer. Here are the main ...

A newly reported case of back-to-back infections with the H3N2 flu strain and COVID-19 is fuelling fresh questions about how ...

A groundbreaking study introduces new noninvasive screening tools that have the potential to greatly enhance patient comfort ...

Global Influenza Diagnostics Market OverviewThe global influenza diagnostics market is projected to expand at a CAGR of 5–8% over the next five years. Market growth is fueled by the rising prevalence ...

The United States DNA polymerase market is projected to reach USD 246.9 million by 2035, supported by rising investments in ...

OU Medicine, University of Oklahoma Health Sciences Center and Oklahoma Medical Research Foundation File for FDA Emergency Use Authorization for COVID-19 Detection Test Utilizing ...

Seegene, Inc., a global leader in molecular diagnostics (MDx), announced today the establishment of a new subsidiary in ...

A new portable DNA test can identify dozens of shark and ray species in only two hours, giving frontline officers a powerful ...